disruptpress efi
Real Estate

Compass, A Much-Hyped Real Estate Startup, Files To Go Public

Compass, a much-hyped residential brokerage, has filed documents with the Securities & Exchange Commission for a possible IPO, the company announced on Monday.

“The number of shares to be offered and the price range for the proposed offering have not yet been determined,” the statement said. It also did not provide a timeline for the offering, other than that it would take place after the SEC’s review process.

Fueled by $1.5 billion in funding, including from SoftBank, Compass has feverishly sought to recruit agents from rival firms. Its valuation has swelled in turn, to a reported $6.4 billion following a $370 million funding round in 2019.

A spokesperson for the company declined to provide additional details on the possible IPO.

Compass was founded in 2012 by Ori Allon and Robert Reffkin, the latter of whom serves as CEO. Reffkin boasts a glossy resume. He previously worked at Goldman Sachs, where he was a vice president before becoming chief of staff to the firm’s president and chief operating officer. Before that, he spent time at McKinsey, Lazard and the Department of the Treasury.

If it completes the IPO, Compass will join a bevy of startups that have gone public in the last year—many facilitated by SPACs, or special purpose acquisition companies— including Opendoor, Airbnb, DoorDash and Snowflake.

The company had a rocky spring at the onset of the pandemic, when it laid off 15% of its staff, according to The Real Deal. Thanks to the frenzied residential real estate market, however, it “reported record revenue in June, July and August.”

MORE FOR YOU

Evidently, Reffkin hopes to strike while the iron is still hot.

Products You May Like

Articles You May Like

Red State Budgets Are Suffering The Most In This Recession
The Reality Of Nomadland Life In America
Texas blackouts show how vulnerable power grid is to climate change
Ask Larry: Will My Wife Get 50% Of My FRA Benefit Or 50% Of My Age 70 Rate?
FDA staff endorses J&J’s single-shot Covid vaccine for emergency use — clearing way for third vaccine in U.S.

Leave a Reply

Your email address will not be published. Required fields are marked *